Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation

Documenti analoghi

• Late‐Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T‐Cell Therapy
  di: Daisuke Ikeda, et al.
  Pubblicazione: (2025)
• Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
  di: Vadim Lesan, et al.
  Pubblicazione: (2024)
• HLA‐matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML
  di: Takaya Mitsuyoshi, et al.
  Pubblicazione: (2025)
• Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia
  di: Yuma Kawamura, et al.
  Pubblicazione: (2024)
• Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
  di: Osamu Imataki, et al.
  Pubblicazione: (2024)